Skip to main content
Clinical Trials/NL-OMON20217
NL-OMON20217
Not yet recruiting
Not Applicable

Transcranial Alternating Current Stimulation (tACS) as a novel treatment option: a proof of concept study in Adult Classic Galactosemia

azM0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Classic Galactosemia
Sponsor
azM
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
azM

Eligibility Criteria

Inclusion Criteria

  • Patient group
  • The patient may participate in the study, if they meet these criteria:
  • \- Adult age: 18 years or older
  • \- GALT enzyme activity below 10% and/or GALT gene severe disease causing mutations
  • \- Motor sequencing and/or word productions problems
  • \- Documented motor and language impairments
  • \- Capable of giving informed consent
  • \- The participants are screened pre and post intervention using standardized tests. Participants with abnormal scores in cognitive and/or motor domains are eligible.
  • Control group
  • Healthy controls are included if they meet the following criteria:

Exclusion Criteria

  • A subject will be excluded from the study, if he meets these criteria:
  • \- Motor and language problems due to other causes
  • \- Psoriasis
  • \- Epilepsy

Outcomes

Primary Outcomes

Not specified

Similar Trials